35 Stocks Moving In Wednesday's Mid-Day Session

Gainers

• Direct Digital Holdings, Inc. DRCT shares jumped 82.6% to $4.71 after the company reported a year over year increase in Q4 sales results and issued Q1 sales guidance above analyst estimates.
• Adagio Therapeutics, Inc. ADGI gained 53.2% to $5.89 after the company announced ADG20 is the first monoclonal antibody to meet primary endpoints with statistical significance across pre- and post-exposure prophylaxis and treatment for COVID-19 and plans to seek US Emergency Use Authorization.
• Insignia Systems, Inc. ISIG shares gained 26% to $11.04.
• Snow Lake Resources Ltd. LITM gained 23.1% to $8.90.
• Vir Biotechnology, Inc. VIR rose 19.7% to $27.02. Vir Biotechnology will join S&P Smallcap 600 index.
• Arhaus, Inc. ARHS rose 18.8% to $8.55 after reporting strong quarterly sales.
• Vyant Bio, Inc. VYNT climbed 17.7% to $1.5892. Vyant Bio and OrganoTherapeutics reported a strategic collaboration to discover therapeutics to treat Parkinson's disease.
• Indonesia Energy Corporation Limited INDO rose 17.1% to $26.57.
• Pear Therapeutics, Inc. PEAR surged 17.2% to $5.39.
• Forge Global Holdings, Inc. FRGE gained 16.9% to $25.31.
• Ambac Financial Group, Inc. AMBC jumped 15.7% to $9.99 after the company authorized a share repurchase program of up to $20 million.
• IN8bio, Inc. INAB gained 15.3% to $3.62.
• Sportradar Group AG SRAD jumped 14.8% to $16.91 after the company reported better-than-expected Q4 sales results.
• PolyMet Mining Corp. PLM gained 13.1% to $3.9450.
• Geron Corporation GERN shares gained 11.3% to $1.4250 after the company reported the pricing of its public offering of common stock and warrants.
• Lululemon Athletica Inc. LULU surged 10.6% to $380.75 after the company reported better-than-expected Q4 EPS results. The company also issued Q1 and FY22 guidance above analyst estimates and reported a $1 billion buyback.
• Reed's, Inc. REED rose 9.8% to $0.2994. Reed’s is scheduled to host a conference call on Thursday, March 31, 2022 time to discuss the financial results for the three months and full year ended December 31, 2021.
• Sonoma Pharmaceuticals, Inc. SNOA rose 8.6% to $3.65. Sonoma Pharmaceuticals launched new urinary tract infection product through distributors in New Zealand, Australia and South Africa.
• Zhangmen Education Inc. ZME rose 8.2% to $1.3201 after reporting Q4 results.

Losers

• Revelation Biosciences, Inc. REVB shares dipped 37.4% to $1.34 after the company said preliminary results from Phase 2b study of REVTx-99a for H3N2 flu infection did not meet primary endpoint.
• Stronghold Digital Mining, Inc.. SDIG fell 32% to $6.97 after the company reported worse-than-expected Q4 sales results.
• Calithera Biosciences, Inc. CALA shares fell 31.2% to $0.4115 as the company priced its $10.0 million underwritten public offering of common stock and warrants to purchase common stock.
• Fast Radius, Inc. FSRD fell 27.7% to $1.34 after the company reported Q4 results.
• The Valens Company Inc. VLNS dropped 22.4% to $1.80 after the company filed for a mixed-securities shelf offering of up to $150 million.
• Akebia Therapeutics, Inc. AKBA fell 17.2% to $2.0194.
• Oblong Inc. OBLG fell 16.8% to $0.6998. Oblong recently posted a Q4 net loss of $2.71 million.
• Starry Group Holdings Inc. STRY dropped 15.5% to $7.78.
• Chewy, Inc. CHWY fell 15.2% to $43.26 after the company reported worse-than-expected Q4 sales results.
• RH RH declined 11.8% to $339.83 after the company reported worse-than-expected Q4 sales results.
• JX Luxventure Limited LLL dropped 9.5% to $3.5750.
• Bed Bath & Beyond Inc. BBBY fell 9.4% to $24.67. Bed Bath & Beyond recently reported a cooperation agreement with Ryan Cohen.
• Conn's, Inc. CONN fell 9.1% to $17.23. Conn's recently said Q4 EPS and sales results were lower from last year.
• Microvast Holdings, Inc. MVST fell 7.7% to $6.85 following 2021 results.
• OpGen, Inc. OPGN shares fell 6.4% to $0.7959 after the company reported fourth-quarter results.
• Pearson plc PSO fell 5.7% to $9.87. Apollo Global Management said it is unable to reach agreement with Pearson board with regard to a takeover offer.